Found: 36
Select item for more details and to access through your institution.
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 697, doi. 10.1007/s10549-020-05981-z
- By:
- Publication type:
- Article
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 817, doi. 10.1007/s10549-020-05978-8
- By:
- Publication type:
- Article
Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 685, doi. 10.1007/s10549-020-05975-x
- By:
- Publication type:
- Article
A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 807, doi. 10.1007/s10549-020-05976-w
- By:
- Publication type:
- Article
To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 677, doi. 10.1007/s10549-020-05974-y
- By:
- Publication type:
- Article
The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 869, doi. 10.1007/s10549-020-06066-7
- By:
- Publication type:
- Article
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 863, doi. 10.1007/s10549-020-06053-y
- By:
- Publication type:
- Article
Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging?
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 567, doi. 10.1007/s10549-020-06047-w
- By:
- Publication type:
- Article
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 557, doi. 10.1007/s10549-020-06030-5
- By:
- Publication type:
- Article
Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 647, doi. 10.1007/s10549-020-06023-4
- By:
- Publication type:
- Article
The wisdom trial is based on faulty reasoning and has major design and execution problems.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 549, doi. 10.1007/s10549-020-06020-7
- By:
- Publication type:
- Article
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 639, doi. 10.1007/s10549-020-06019-0
- By:
- Publication type:
- Article
Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 629, doi. 10.1007/s10549-020-06015-4
- By:
- Publication type:
- Article
A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 533, doi. 10.1007/s10549-020-06009-2
- By:
- Publication type:
- Article
Implant-based breast reconstruction: re-analysis of the odds ratio for skin flap necrosis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 615, doi. 10.1007/s10549-020-05999-3
- By:
- Publication type:
- Article
The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 601, doi. 10.1007/s10549-020-05997-5
- By:
- Publication type:
- Article
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 591, doi. 10.1007/s10549-020-05996-6
- By:
- Publication type:
- Article
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 759, doi. 10.1007/s10549-020-05995-7
- By:
- Publication type:
- Article
Re: Naoum et al., Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 741, doi. 10.1007/s10549-020-05991-x
- By:
- Publication type:
- Article
The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 709, doi. 10.1007/s10549-020-05988-6
- By:
- Publication type:
- Article
Letter to the editor regarding the article "Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 583, doi. 10.1007/s10549-020-05986-8
- By:
- Publication type:
- Article
Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 851, doi. 10.1007/s10549-020-05985-9
- By:
- Publication type:
- Article
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 841, doi. 10.1007/s10549-020-05984-w
- By:
- Publication type:
- Article
Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American women.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 831, doi. 10.1007/s10549-020-05983-x
- By:
- Publication type:
- Article
New anti-HER2 agents for brain metastasis: histology-agnostic weapons?
- Published in:
- 2021
- By:
- Publication type:
- Letter
Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 799, doi. 10.1007/s10549-020-05973-z
- By:
- Publication type:
- Article
Association between statin use and second cancer risk in breast cancer patients: a nationwide population-based cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 773, doi. 10.1007/s10549-020-05969-9
- By:
- Publication type:
- Article
Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 573, doi. 10.1007/s10549-020-05977-9
- By:
- Publication type:
- Article
The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 667, doi. 10.1007/s10549-020-05971-1
- By:
- Publication type:
- Article
Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 785, doi. 10.1007/s10549-020-05972-0
- By:
- Publication type:
- Article
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 657, doi. 10.1007/s10549-020-05970-2
- By:
- Publication type:
- Article